Profile
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead program for TNBC will be ready for IND in H1-2025. Its platform has been validated (in-vivo and with unprecedented in-vitro characteristics) with three top 25 pharma companies in their experimental assays. ProteinQure is the only computational platform capable of designing peptides with the full complement of non-canonical amino acids, so that its peptides are 100x better than natural peptide ligands. For its own internal programs ProteinQure uses the novel peptides to help deliver payloads in a tissue specific manner. Peptides are ideal for delivery of different payloads like radioisotopes and gene therapy since they are tissue specific and easier to manufacture. ProteinQure is also have exciting in-vivo POC for siRNA delivery to CNS.
Website
Contact
-
Lucas Siow, Chief Executive OfficerTel: +1 647-248-9772Email: lucas@proteinqure.com
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
CanaQuest is a clinical-stage life sciences company developing innovative cannabinoid-based therapeutics. Its… -
Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from… -
Healthyher.Life is a women’s health navigator platform for its member community of women and gender-diverse… -
Hole Medical Ltd. is a pioneering digital health aggregator at the forefront of healthcare innovation. Its… -
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics… -
For over two decades, Inertia has been the trusted partner for start-ups in the medical device, diagnostic, and… -
JN Nova Pharma is a Canadian biotech company collaborating with the National Research Council of… -
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
-
PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders by leveraging… -
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and… -
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small…